Announced Fri, 17 Jul · 13:19 IST
Board to consider Q1FY27 results and interim dividend on July 24
Results View source PDF
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.2%1-day move
₹1718.00
prior close
₹1696.10
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0+0.0-0.1+0.3-1.2-0.6-0.7-1.6+3.0—————
Up moveDown movePending
AI summary
Dr. Lal Path Labs board will meet on July 24, 2026 to consider and approve unaudited standalone and consolidated financial results for Q1 ended June 30, 2026. The board will also consider an interim dividend, if any, on equity shares for FY 2026-27. This is an advance intimation ahead of the Q1 earnings announcement.
Likely market impact
Watch for Q1 results and any interim dividend declaration, which could be a positive trigger for the stock.